Prion-like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG repeat expansions in the huntingtin gene resulting in the synthesis of a misfolded form of the huntingtin protein (mHTT) which is toxic. The current treatments for HD are only palliative. Some of the potential therapies for HD include gene therapy (using antisense oligonucleotides and clustered regularly interspaced short palindromic repeats-Cas9 system) and stem-cell-based therapies. Various types of stem cell transplants, such as mesenchymal stem cells, neural stem cells, and reprogrammed stem cells, have the potential to either replace the lost neurons or support the existing neurons by releasing trophic factors. Most of the transplants are xenografts and allografts; however, recent reports on HD patients who received grafts suggest that the mHTT aggregates are transferred from the host neurons to the grafted cells as well as to the surrounding areas of the graft by a “prion-like” mechanism. This observation seems to be true for autotransplantation paradigms, as well. This article reviews the different types of stem cells that have been transplanted into HD patients and their therapeutic efficacy, focusing on the transfer of mHTT from the host cells to the graft. Autotransplants of reprogramed stem cells in HD patients are a promising therapeutic option. However, this needs further attention to ensure a better understanding of the transfer of mHTT aggregates following transplantation of the gene-corrected cells back into the patient.

Original languageEnglish
Pages (from-to)559-566
Number of pages8
JournalStem Cells Translational Medicine
Volume9
Issue number5
DOIs
StatePublished - May 1 2020

Keywords

  • Huntington's disease
  • mHTT aggregates
  • prion
  • stem cells
  • transplantation

Fingerprint

Dive into the research topics of 'Prion-like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy'. Together they form a unique fingerprint.

Cite this